患者制御注射器の世界市場レポート 2025年

患者制御注射器市場規模は、今後数年で急成長が見込まれます。2029年にはCAGR12.8％で82億5,000万米ドルに成長します。予測期間の成長は、高齢化人口の増加、慢性呼吸器疾患の罹患率の上昇、慢性疾患の有病率の増加、がん罹患率の増加、自己免疫疾患の有病率の増加に起因しています。予測期間の主な動向には、技術的進歩、人工知能の統合、遠隔医療、遠隔モニタリング、携帯型およびウェアラブルデバイスの進歩、低侵襲処置の重視などがあります。

慢性疾患の有病率の上昇は、今後数年間における患者制御注射器市場の成長を促進する見通しです。高齢化、肥満の流行、社会経済状況、環境要因などの要因により、3カ月以上持続し、時間の経過とともに悪化することが多い慢性疾患が増加しています。患者管理注射器により、患者は正確かつ便利に、治療スケジュールに従って薬を自己投与することができます。例えば、国立生物工学情報センター（NCBI）は2023年1月に、1つ以上の慢性疾患を有する50歳以上の個人の数が、2020年の7,152万人から2050年までに99.5％増加し、1億4,266万人になると予測しました。したがって、慢性疾患の有病率の増加は、患者管理注射器市場を前進させると予想されます。

この市場の主要企業は、顧客のニーズをよりよく満たすために、すぐに使える注射器などの先進製品を開発し、技術革新を進めています。すぐに使える注射器は、正確な量の薬剤があらかじめ充填・滅菌されているため、手作業による準備の必要がなく、汚染や投与ミスのリスクを軽減することができます。例えば、2022年10月、イプソメドAGは、1.5～5.5mlの液体医薬品用に調整された新しい自動注射器プラットフォームを発表しました。この装置は、人間工学に基づいた使いやすいデザインで、注射中の患者の快適性を確保するとともに、針刺し事故を防止する高度な安全機構を備えています。また、さまざまな粘度に対応できるため、さまざまな治療用途に多用途に使用できます。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、新型コロナウイルス感染症、そして景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界患者制御注射器PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の患者制御注射器市場：成長率分析
• 世界の患者制御注射器市場の実績：規模と成長, 2019-2024
• 世界の患者制御注射器市場の予測：規模と成長, 2024-2029, 2034F
• 世界患者制御注射器総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の患者制御注射器市場：製品別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 電子ウェアラブルインジェクター
• 機械式ウェアラブルインジェクター
• 輸液ポンプ
• 世界の患者制御注射器市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• がん治療
• 自己免疫治療
• 血液疾患の治療
• その他のアプリケーション
• 世界の患者制御注射器市場：流通チャネル別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院薬局
• 小売薬局
• 通信販売薬局
• 世界の患者制御注射器市場、電子ウェアラブルインジェクターのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• プレフィルド電子ウェアラブルインジェクター
• プログラム可能な電子ウェアラブルインジェクター
• スマート電子ウェアラブルインジェクター
• 充電式電子ウェアラブルインジェクター
• Bluetooth対応ウェアラブル電子インジェクター
• 使い捨て電子ウェアラブルインジェクター
• 世界の患者制御注射器市場機械式ウェアラブルインジェクターのサブセグメンテーション（タイプ別）、実績と予測, 2019-2024, 2024-2029F, 2034F
• バネ式機械式ウェアラブルインジェクター
• ピストン式機械式ウェアラブルインジェクター
• 自動注射器（機械式）
• 手動機械式ウェアラブルインジェクター
• 使い捨て機械式ウェアラブルインジェクター
• 世界の患者制御注射器市場輸液ポンプのサブセグメンテーション（タイプ別）、実績と予測, 2019-2024, 2024-2029F, 2034F
• 使い捨て輸液ポンプ
• プログラム可能な輸液ポンプ
• インスリン注入ポンプ
• シリンジ輸液ポンプ
• 携帯型輸液ポンプ
• 大容量輸液ポンプ
• 埋め込み型輸液ポンプ

第7章 地域別・国別分析

• 世界の患者制御注射器市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の患者制御注射器市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 患者制御注射器市場：競合情勢
• 患者制御注射器市場：企業プロファイル
  • Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
  • Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
  • West Pharmaceutical Services Overview, Products and Services, Strategy and Financial Analysis
  • SCHOTT AG Overview, Products and Services, Strategy and Financial Analysis
  • Gerresheimer AG Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Phillips-Medisize
• Vetter Pharma-Fertigung GmbH & Co. KG
• Stevanato Group
• Ypsomed AG
• Nemera
• B. Braun Melsungen AG
• Elcam Medical
• Owen Mumford
• Bespak
• Unilife Corporation
• Crossject
• SHL Group
• AptarGroup Inc.
• Credence MedSystems
• Weibel CDS AG

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 患者制御注射器市場2029：新たな機会を提供する国
• 患者制御注射器市場2029：新たな機会を提供するセグメント
• 患者制御注射器市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Patient-controlled injectors are medical devices designed to empower patients to self-administer medication with precise control over dosage and timing. They are user-friendly, facilitating independent management of treatment, typically in home settings.

The primary types of patient-controlled injectors include electronic wearable injectors, mechanical wearable injectors, and infusion pumps. Electronic versions enable automated and precise medication delivery, often equipped with connectivity features for tracking and monitoring usage. This enhances convenience and provides data-driven insights for patients. These devices find applications in treatments such as cancer, autoimmune disorders, and blood disorders, distributed through hospital pharmacies, retail pharmacies, and mail-order channels.

The patient-controlled injectors market research report is one of a series of new reports from The Business Research Company that provides patient-controlled injectors market statistics, including patient-controlled injectors industry global market size, regional shares, competitors with a patient-controlled injectors market share, detailed patient-controlled injectors market segments, market trends, and opportunities, and any further data you may need to thrive in the patient-controlled injectors industry. This patient-controlled injectors research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The patient controlled injectors market size has grown rapidly in recent years. It will grow from $4.51 billion in 2024 to $5.1 billion in 2025 at a compound annual growth rate (CAGR) of 13.1%. The growth in the historic period can be attributed to growth in home healthcare, expansion of healthcare infrastructure, increasing cases of diabetes, increased prevalence of infectious diseases, and increasing focus on personalized medicine.

The patient controlled injectors market size is expected to see rapid growth in the next few years. It will grow to $8.25 billion in 2029 at a compound annual growth rate (CAGR) of 12.8%. The growth in the forecast period can be attributed to a rising aging population, rising incidence of chronic respiratory diseases, increasing prevalence of chronic diseases, increasing cancer cases, and increasing autoimmune disorders prevalence. Major trends in the forecast period include technological advancements, integration of artificial intelligence, telemedicine, remote monitoring, advancements in portable and wearable devices, and focus on minimally invasive procedures.

The rising prevalence of chronic diseases is poised to drive the growth of the patient-controlled injectors market in the coming years. Chronic illnesses, lasting three months or more and often worsening over time, are increasing due to factors such as an aging population, the obesity epidemic, socioeconomic conditions, and environmental factors. Patient-controlled injectors enable individuals to self-administer medications accurately, conveniently, and according to their treatment schedules. For example, the National Center for Biotechnology Information (NCBI) projected in January 2023 that the number of individuals aged 50 and older with one or more chronic conditions will rise by 99.5% by 2050, from 71.52 million in 2020 to 142.66 million. Therefore, the growing prevalence of chronic diseases is expected to propel the patient-controlled injectors market forward.

Leading companies in this market are innovating by developing advanced products such as ready-to-use syringes to better meet customer needs. Ready-to-use syringes come prefilled and sterilized with a precise dose of medication, eliminating the need for manual preparation and reducing risks of contamination and dosing errors. For instance, in October 2022, Ypsomed AG introduced a new autoinjector platform tailored for liquid pharmaceuticals ranging from 1.5 to 5.5 ml. This device features ergonomic design for ease of use, ensuring patient comfort during injections, along with advanced safety mechanisms to prevent accidental needle sticks. It provides visual and audible feedback to confirm successful medication delivery and is versatile for various therapeutic applications due to its compatibility with different viscosities.

In April 2023, LTS Lohmann Therapie-Systeme AG expanded its drug delivery portfolio by acquiring the sorrel wearable injection device business from Eitan Medical. This acquisition enhances LTS's capabilities in advanced wearable injection technologies, further solidifying its presence in the patient-controlled injectors market. Eitan Medical Ltd. is an Israel-based company that develops innovative drug delivery devices, including patient-controlled injectors.

Major companies operating in the patient controlled injectors market are Medtronic plc, Becton Dickinson and Company, West Pharmaceutical Services, SCHOTT AG, Gerresheimer AG, Phillips-Medisize, Vetter Pharma-Fertigung GmbH & Co. KG, Stevanato Group, Ypsomed AG, Nemera, B. Braun Melsungen AG, Elcam Medical, Owen Mumford, Bespak, Unilife Corporation, Crossject, SHL Group, AptarGroup Inc., Credence MedSystems, Weibel CDS AG, Sorrel Medical

North America was the largest region in the patient controlled injectors market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the patient controlled injectors market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the patient controlled injectors market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The patient-controlled injectors market consists of sales of prefilled syringes, auto-injectors, on-body injectors, and needle-free injectors. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Patient Controlled Injectors Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on patient controlled injectors market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for patient controlled injectors ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The patient controlled injectors market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Electronic Wearable Injector; Mechanical Wearable Injector; Infusion Pumps
• 2) By Application: Cancer Treatment; Auto-Immune Treatment; Blood Disorder Treatment; Other Application
• 3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Mail Order Pharmacies
• Subsegments:
• 1) By Electronic Wearable Injector: Pre-Filled Electronic Wearable Injectors; Programmable Electronic Wearable Injectors; Smart Electronic Wearable Injectors; Rechargeable Electronic Wearable Injectors; Bluetooth-Enabled Electronic Wearable Injectors; Disposable Electronic Wearable Injectors
• 2) By Mechanical Wearable Injector: Spring-Loaded Mechanical Wearable Injectors; Piston-Based Mechanical Wearable Injectors; Auto-Injectors (Mechanical); Manual Mechanical Wearable Injectors; Disposable Mechanical Wearable Injectors
• 3) By Infusion Pumps: Disposable Infusion Pumps; Programmable Infusion Pumps; Insulin Infusion Pumps; Syringe Infusion Pumps; Ambulatory Infusion Pumps; Large Volume Infusion Pumps; Implantable Infusion Pumps
• Companies Mentioned: Medtronic plc; Becton Dickinson and Company; West Pharmaceutical Services; SCHOTT AG; Gerresheimer AG
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Patient Controlled Injectors Market Characteristics

3. Patient Controlled Injectors Market Trends And Strategies

4. Patient Controlled Injectors Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Patient Controlled Injectors Growth Analysis And Strategic Analysis Framework

• 5.1. Global Patient Controlled Injectors PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Patient Controlled Injectors Market Growth Rate Analysis
• 5.4. Global Patient Controlled Injectors Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Patient Controlled Injectors Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Patient Controlled Injectors Total Addressable Market (TAM)

6. Patient Controlled Injectors Market Segmentation

• 6.1. Global Patient Controlled Injectors Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Electronic Wearable Injector
• Mechanical Wearable Injector
• Infusion Pumps
• 6.2. Global Patient Controlled Injectors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cancer Treatment
• Auto-Immune Treatment
• Blood Disorder Treatment
• Other Application
• 6.3. Global Patient Controlled Injectors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacies
• Retail Pharmacies
• Mail Order Pharmacies
• 6.4. Global Patient Controlled Injectors Market, Sub-Segmentation Of Electronic Wearable Injector, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pre-Filled Electronic Wearable Injectors
• Programmable Electronic Wearable Injectors
• Smart Electronic Wearable Injectors
• Rechargeable Electronic Wearable Injectors
• Bluetooth-Enabled Electronic Wearable Injectors
• Disposable Electronic Wearable Injectors
• 6.5. Global Patient Controlled Injectors Market, Sub-Segmentation Of Mechanical Wearable Injector, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Spring-Loaded Mechanical Wearable Injectors
• Piston-Based Mechanical Wearable Injectors
• Auto-Injectors (Mechanical)
• Manual Mechanical Wearable Injectors
• Disposable Mechanical Wearable Injectors
• 6.6. Global Patient Controlled Injectors Market, Sub-Segmentation Of Infusion Pumps, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Disposable Infusion Pumps
• Programmable Infusion Pumps
• Insulin Infusion Pumps
• Syringe Infusion Pumps
• Ambulatory Infusion Pumps
• Large Volume Infusion Pumps
• Implantable Infusion Pumps

7. Patient Controlled Injectors Market Regional And Country Analysis

• 7.1. Global Patient Controlled Injectors Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Patient Controlled Injectors Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Patient Controlled Injectors Market

• 8.1. Asia-Pacific Patient Controlled Injectors Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Patient Controlled Injectors Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Patient Controlled Injectors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Patient Controlled Injectors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Patient Controlled Injectors Market

• 9.1. China Patient Controlled Injectors Market Overview
• 9.2. China Patient Controlled Injectors Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Patient Controlled Injectors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Patient Controlled Injectors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Patient Controlled Injectors Market

• 10.1. India Patient Controlled Injectors Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Patient Controlled Injectors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Patient Controlled Injectors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Patient Controlled Injectors Market

• 11.1. Japan Patient Controlled Injectors Market Overview
• 11.2. Japan Patient Controlled Injectors Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Patient Controlled Injectors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Patient Controlled Injectors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Patient Controlled Injectors Market

• 12.1. Australia Patient Controlled Injectors Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Patient Controlled Injectors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Patient Controlled Injectors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Patient Controlled Injectors Market

• 13.1. Indonesia Patient Controlled Injectors Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Patient Controlled Injectors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Patient Controlled Injectors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Patient Controlled Injectors Market

• 14.1. South Korea Patient Controlled Injectors Market Overview
• 14.2. South Korea Patient Controlled Injectors Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Patient Controlled Injectors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Patient Controlled Injectors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Patient Controlled Injectors Market

• 15.1. Western Europe Patient Controlled Injectors Market Overview
• 15.2. Western Europe Patient Controlled Injectors Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Patient Controlled Injectors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Patient Controlled Injectors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Patient Controlled Injectors Market

• 16.1. UK Patient Controlled Injectors Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Patient Controlled Injectors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Patient Controlled Injectors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Patient Controlled Injectors Market

• 17.1. Germany Patient Controlled Injectors Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Patient Controlled Injectors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Patient Controlled Injectors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Patient Controlled Injectors Market

• 18.1. France Patient Controlled Injectors Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Patient Controlled Injectors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Patient Controlled Injectors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Patient Controlled Injectors Market

• 19.1. Italy Patient Controlled Injectors Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Patient Controlled Injectors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Patient Controlled Injectors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Patient Controlled Injectors Market

• 20.1. Spain Patient Controlled Injectors Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Patient Controlled Injectors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Patient Controlled Injectors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Patient Controlled Injectors Market

• 21.1. Eastern Europe Patient Controlled Injectors Market Overview
• 21.2. Eastern Europe Patient Controlled Injectors Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Patient Controlled Injectors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Patient Controlled Injectors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Patient Controlled Injectors Market

• 22.1. Russia Patient Controlled Injectors Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Patient Controlled Injectors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Patient Controlled Injectors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Patient Controlled Injectors Market

• 23.1. North America Patient Controlled Injectors Market Overview
• 23.2. North America Patient Controlled Injectors Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Patient Controlled Injectors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Patient Controlled Injectors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Patient Controlled Injectors Market

• 24.1. USA Patient Controlled Injectors Market Overview
• 24.2. USA Patient Controlled Injectors Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Patient Controlled Injectors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Patient Controlled Injectors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Patient Controlled Injectors Market

• 25.1. Canada Patient Controlled Injectors Market Overview
• 25.2. Canada Patient Controlled Injectors Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Patient Controlled Injectors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Patient Controlled Injectors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Patient Controlled Injectors Market

• 26.1. South America Patient Controlled Injectors Market Overview
• 26.2. South America Patient Controlled Injectors Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Patient Controlled Injectors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Patient Controlled Injectors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Patient Controlled Injectors Market

• 27.1. Brazil Patient Controlled Injectors Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Patient Controlled Injectors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Patient Controlled Injectors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Patient Controlled Injectors Market

• 28.1. Middle East Patient Controlled Injectors Market Overview
• 28.2. Middle East Patient Controlled Injectors Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Patient Controlled Injectors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Patient Controlled Injectors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Patient Controlled Injectors Market

• 29.1. Africa Patient Controlled Injectors Market Overview
• 29.2. Africa Patient Controlled Injectors Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Patient Controlled Injectors Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Patient Controlled Injectors Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Patient Controlled Injectors Market Competitive Landscape And Company Profiles

• 30.1. Patient Controlled Injectors Market Competitive Landscape
• 30.2. Patient Controlled Injectors Market Company Profiles
  • 30.2.1. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. West Pharmaceutical Services Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. SCHOTT AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Gerresheimer AG Overview, Products and Services, Strategy and Financial Analysis

31. Patient Controlled Injectors Market Other Major And Innovative Companies

• 31.1. Phillips-Medisize
• 31.2. Vetter Pharma-Fertigung GmbH & Co. KG
• 31.3. Stevanato Group
• 31.4. Ypsomed AG
• 31.5. Nemera
• 31.6. B. Braun Melsungen AG
• 31.7. Elcam Medical
• 31.8. Owen Mumford
• 31.9. Bespak
• 31.10. Unilife Corporation
• 31.11. Crossject
• 31.12. SHL Group
• 31.13. AptarGroup Inc.
• 31.14. Credence MedSystems
• 31.15. Weibel CDS AG

32. Global Patient Controlled Injectors Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Patient Controlled Injectors Market

34. Recent Developments In The Patient Controlled Injectors Market

35. Patient Controlled Injectors Market High Potential Countries, Segments and Strategies

• 35.1 Patient Controlled Injectors Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Patient Controlled Injectors Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Patient Controlled Injectors Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer